Home » Market Research » Buy Recommendations » Regeneron Pharmaceuticals Inc
Balfour Capital Group Researched Regeneron Pharmaceuticals Inc
on March 14th, 2023.
Regeneron Pharmaceuticals (REGN) is a biotechnology company specializing in innovative treatments for various medical conditions, known for its advancements in research and drug development.